JP7502860B2 - Cleaning composition - Google Patents
Cleaning composition Download PDFInfo
- Publication number
- JP7502860B2 JP7502860B2 JP2019237846A JP2019237846A JP7502860B2 JP 7502860 B2 JP7502860 B2 JP 7502860B2 JP 2019237846 A JP2019237846 A JP 2019237846A JP 2019237846 A JP2019237846 A JP 2019237846A JP 7502860 B2 JP7502860 B2 JP 7502860B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- component
- skin
- examples
- isethionate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 62
- 238000004140 cleaning Methods 0.000 title claims description 20
- -1 fatty acid salt Chemical class 0.000 claims description 55
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 22
- 239000000194 fatty acid Substances 0.000 claims description 22
- 229930195729 fatty acid Natural products 0.000 claims description 22
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- 239000002280 amphoteric surfactant Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 150000001412 amines Chemical class 0.000 claims description 8
- 239000006227 byproduct Substances 0.000 claims description 8
- 239000013543 active substance Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 description 130
- 229920001296 polysiloxane Polymers 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 25
- 238000011282 treatment Methods 0.000 description 22
- 239000003599 detergent Substances 0.000 description 21
- 239000000843 powder Substances 0.000 description 21
- 239000004615 ingredient Substances 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 16
- 239000006260 foam Substances 0.000 description 15
- 230000007794 irritation Effects 0.000 description 14
- 239000000049 pigment Substances 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 238000005187 foaming Methods 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 239000000344 soap Substances 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 241001474374 Blennius Species 0.000 description 8
- 239000012190 activator Substances 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- 239000000419 plant extract Substances 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 6
- 230000001815 facial effect Effects 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 230000008591 skin barrier function Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 244000144730 Amygdalus persica Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000010306 acid treatment Methods 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 229940008396 carrot extract Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000002826 coolant Substances 0.000 description 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 235000020717 hawthorn extract Nutrition 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 235000020737 peppermint extract Nutrition 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 229920002050 silicone resin Polymers 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000001430 tilia cordata extract Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 244000061520 Angelica archangelica Species 0.000 description 3
- 235000007650 Aralia spinosa Nutrition 0.000 description 3
- 244000118154 Aralia spinosa Species 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 239000012459 cleaning agent Substances 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 240000000073 Achillea millefolium Species 0.000 description 2
- 235000007754 Achillea millefolium Nutrition 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 244000298697 Actinidia deliciosa Species 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000092668 Artemisia capillaris Species 0.000 description 2
- 235000008658 Artemisia capillaris Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000951471 Citrus junos Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 241000212948 Cnidium Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 2
- 244000061508 Eriobotrya japonica Species 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 241000208680 Hamamelis mollis Species 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 2
- 244000130592 Hibiscus syriacus Species 0.000 description 2
- 235000013719 Houttuynia cordata Nutrition 0.000 description 2
- 240000000691 Houttuynia cordata Species 0.000 description 2
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 2
- 244000267823 Hydrangea macrophylla Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 241000546188 Hypericum Species 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241001071917 Lithospermum Species 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241000276489 Merlangius merlangus Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- WAYLDHLWVYQNSQ-KEFDUYNTSA-N N-2-hydroxylignoceroylsphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC WAYLDHLWVYQNSQ-KEFDUYNTSA-N 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 241000972673 Phellodendron amurense Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 240000001341 Reynoutria japonica Species 0.000 description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 description 2
- 241000109365 Rosa arkansana Species 0.000 description 2
- 235000005066 Rosa arkansana Nutrition 0.000 description 2
- 239000009724 Salvia extract Substances 0.000 description 2
- 244000151637 Sambucus canadensis Species 0.000 description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 description 2
- 240000003946 Saponaria officinalis Species 0.000 description 2
- 241000543810 Sasa veitchii Species 0.000 description 2
- 241001647091 Saxifraga granulata Species 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- 240000003377 Shepherdia canadensis Species 0.000 description 2
- 235000018324 Shepherdia canadensis Nutrition 0.000 description 2
- 239000006087 Silane Coupling Agent Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 241000246044 Sophora flavescens Species 0.000 description 2
- 241001530209 Swertia Species 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- UUGFSANEJDLBBJ-UQKRIMTDSA-N [Na].CCCCCCCCCCCC(=O)N(C)[C@@H](C)C(O)=O Chemical compound [Na].CCCCCCCCCCCC(=O)N(C)[C@@H](C)C(O)=O UUGFSANEJDLBBJ-UQKRIMTDSA-N 0.000 description 2
- 229920006322 acrylamide copolymer Polymers 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 235000019206 astragalus extract Nutrition 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 235000007123 blue elder Nutrition 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229940099417 ceramide 2 Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001841 cholesterols Chemical class 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 229910000423 chromium oxide Inorganic materials 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 229940012466 egg shell membrane Drugs 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 235000007124 elderberry Nutrition 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- 229940072117 fennel extract Drugs 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229940065115 grapefruit extract Drugs 0.000 description 2
- 229960002350 guaiazulen Drugs 0.000 description 2
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 235000020721 horse chestnut extract Nutrition 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 229940045996 isethionic acid Drugs 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 229940071085 lauroyl glutamate Drugs 0.000 description 2
- 229940083980 lavender extract Drugs 0.000 description 2
- 235000020723 lavender extract Nutrition 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 2
- 239000000391 magnesium silicate Substances 0.000 description 2
- 229910052919 magnesium silicate Inorganic materials 0.000 description 2
- 235000019792 magnesium silicate Nutrition 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229940078812 myristyl myristate Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 235000013557 nattō Nutrition 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 229960003351 prussian blue Drugs 0.000 description 2
- 239000013225 prussian blue Substances 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 150000004609 retinol derivatives Chemical class 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 2
- 229960002703 undecylenic acid Drugs 0.000 description 2
- 229940045136 urea Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 239000003357 wound healing promoting agent Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- QCTZUSWOKFCWNB-QXMHVHEDSA-N (z)-n,n-dimethyloctadec-9-en-1-amine oxide Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)[O-] QCTZUSWOKFCWNB-QXMHVHEDSA-N 0.000 description 1
- XEFAJZOBODPHBG-UHFFFAOYSA-N 1-phenoxyethanol Chemical compound CC(O)OC1=CC=CC=C1 XEFAJZOBODPHBG-UHFFFAOYSA-N 0.000 description 1
- JIFGDHWVYVXWCX-UHFFFAOYSA-N 2-[dodecyl(hydroxy)amino]ethane-1,1-diol Chemical compound CCCCCCCCCCCCN(O)CC(O)O JIFGDHWVYVXWCX-UHFFFAOYSA-N 0.000 description 1
- UXPUMTCLHVWFKC-UHFFFAOYSA-N 2-dodecanoyloxyethanesulfonic acid Chemical compound CCCCCCCCCCCC(=O)OCCS(O)(=O)=O UXPUMTCLHVWFKC-UHFFFAOYSA-N 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 239000004266 EU approved firming agent Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- JNGWKQJZIUZUPR-UHFFFAOYSA-N [3-(dodecanoylamino)propyl](hydroxy)dimethylammonium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-] JNGWKQJZIUZUPR-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229940079840 cocoyl isethionate Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- WUIVWRSHESPBPX-GXKRWWSZSA-L disodium;(2s)-2-(dodecanoylamino)butanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC([O-])=O WUIVWRSHESPBPX-GXKRWWSZSA-L 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940026210 lauramidopropylamine oxide Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940071096 lauroyl isethionate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100001067 mild skin irritation Toxicity 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- DKPKKUQZFWYBRB-UHFFFAOYSA-N n,n-dimethyl-3-(tetradecanoylamino)propan-1-amine oxide Chemical compound CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-] DKPKKUQZFWYBRB-UHFFFAOYSA-N 0.000 description 1
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- UNXCZDNUXJJWHY-DFWYDOINSA-M sodium (2S)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].C[C@H](O)CS([O-])(=O)=O UNXCZDNUXJJWHY-DFWYDOINSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940078455 sodium lauroyl aspartate Drugs 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- JYKSTGLAIMQDRA-UHFFFAOYSA-N tetraglycerol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO JYKSTGLAIMQDRA-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、洗浄剤組成物に関し、詳細には、メイクアップ化粧料や顔の汚れに対する十分な洗浄機能を有しながら、皮膚に対する刺激が少なく、洗浄による肌のバリア機能低下を抑制することができる洗浄剤組成物に関するものである。 The present invention relates to a cleansing composition, and more specifically, to a cleansing composition that has sufficient cleansing properties against makeup cosmetics and facial dirt, while being gentle on the skin and preventing a decrease in the skin's barrier function due to cleansing.
従来、アシルイセチオン酸塩又はアシルアルキルイセチオン酸塩を主とする原料が、石鹸の改質洗浄剤として開発されてきた(例えば、非特許文献1)。 So far, raw materials mainly consisting of acyl isethionate or acylalkyl isethionate have been developed as modified detergents for soap (e.g., Non-Patent Document 1).
また、化学構造的に脂肪酸とイセチオン酸塩又はアルキルイセチオン酸塩をエステル化して得られるココイルイセチオン酸塩、ラウロイルイセチオン酸塩、ココイルアルキルイセチオン酸塩、ラウロイルアルキルイセチオン酸塩等を主とする洗浄剤原料が市販されており、硬水でも石鹸に近い豊かでクリーミィな泡立ちが得られ、更に皮膚への浸透残留性が低く、洗顔時の不快な感触である「つっぱり感」が、石鹸に比べて低いことが知られている(例えば、非特許文献1~3)。 In addition, detergent raw materials that are mainly composed of cocoyl isethionate, lauroyl isethionate, cocoyl alkyl isethionate, lauroyl alkyl isethionate, etc., which are obtained by esterifying fatty acids with isethionate or alkyl isethionate, are commercially available, and are known to produce a rich, creamy lather similar to that of soap even in hard water, have low penetration and residual properties on the skin, and cause less of the unpleasant "tightness" that occurs when washing the face than soap (for example, Non-Patent Documents 1 to 3).
しかしながら、非特許文献1~3に記載のイセチオン酸塩又はアルキルイセチオン酸塩の脂肪酸エステルの製造工程においては、未反応状態の脂肪酸及び脂肪酸塩が副生成物として最終反応混合物中に存在しており、それらの種々の炭素鎖の脂肪酸塩のうち、特に脂肪酸組成中の比率の高いラウリン酸塩が皮膚への吸着性が高いことから、洗顔後の肌荒れなどの皮膚刺激性を引き起こす可能性がある。 However, in the manufacturing process of fatty acid esters of isethionate or alkylisethionate described in Non-Patent Documents 1 to 3, unreacted fatty acids and fatty acid salts are present as by-products in the final reaction mixture, and among the fatty acid salts of various carbon chains, laurate, which has a particularly high ratio in the fatty acid composition, is highly adsorbed to the skin and may cause skin irritation such as rough skin after washing the face.
一方で、アニオン性界面活性剤を主として用いる洗浄剤に関しては、従来から皮膚上成分の選択洗浄性に着目した報告がいくつかなされている。例えば、高級脂肪酸と塩基性アミノ酸または無機アルカリとの石鹸と保湿剤および水溶性高分子を組み合わせて洗浄料を配合することにより、細胞間脂質やNMF(Natural Moisturing Factor)を残存させることができることが知られている。 On the other hand, there have been several reports of cleansers that primarily use anionic surfactants that focus on the selective cleansing of skin components. For example, it is known that by formulating a cleanser that combines a soap of higher fatty acids and basic amino acids or inorganic alkali with a moisturizer and a water-soluble polymer, it is possible to leave intercellular lipids and NMF (Natural Moisturizing Factor) behind.
肌に優しいという観点から、アニオン性界面活性剤と比較し皮膚に対する刺激が少ないという特徴を有する両性界面活性剤の開発が進み、近年洗顔料への両性界面活性剤の利用も広がっている。 From the perspective of being gentle to the skin, amphoteric surfactants, which have the characteristic of being less irritating to the skin than anionic surfactants, have been developed, and in recent years the use of amphoteric surfactants in facial cleansers has also become widespread.
本発明は、上記課題を鑑みてなされたものであり、その目的は、メイクアップ化粧料や顔の汚れに対する十分な洗浄機能を有しながらも、皮膚に対する刺激が低く、かつ洗浄による肌のバリア機能低下を抑制することができる洗浄剤組成物を提供することである。 The present invention has been made in consideration of the above problems, and its purpose is to provide a cleansing composition that has sufficient cleansing function against makeup cosmetics and facial dirt, while being less irritating to the skin and capable of suppressing a decrease in the skin's barrier function due to cleansing.
本発明者らは上記目的を達成するため鋭意研究を行った結果、(A)アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩を含有する活性剤組成物と、(B)アミンオキシド型両性界面活性剤を含有することによって、メイクアップ化粧料や顔の汚れに対する十分な洗浄機能を有しながら、皮膚に対する刺激が低く、かつ洗浄による肌のバリア機能低下を抑制することができる洗浄剤組成物となることを見出し、本発明を完成した。 As a result of intensive research conducted by the present inventors to achieve the above object, they discovered that by containing (A) an activator composition containing an acyl isethionate and/or an acylalkyl isethionate, and (B) an amine oxide type amphoteric surfactant, a cleanser composition can be obtained which has sufficient cleansing properties against makeup cosmetics and facial dirt, while being less irritating to the skin and capable of suppressing a decrease in the skin's barrier function due to cleansing, and thus completed the present invention.
第一の発明は、下記成分(A)及び(B)を含有する、洗浄剤組成物。
(A)アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩、並びに前記アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩の製造時の副生成物である脂肪酸及び/又は脂肪酸塩を含有する活性剤であって、前記アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩の含有量は水を含まない前記活性剤の総量に対して80質量%以上である活性剤、
(B)アミンオキシド型両性界面活性剤
The first invention is a cleaning composition comprising the following components (A) and (B):
(A) an active agent containing an acyl isethionate and/or an acylalkyl isethionate, and a fatty acid and/or a fatty acid salt which is a by-product during the production of the acyl isethionate and/or the acylalkyl isethionate, wherein the content of the acyl isethionate and/or the acylalkyl isethionate is 80% by mass or more based on the total amount of the active agent excluding water;
(B) Amine oxide type amphoteric surfactant
第二の発明は、上記成分(A)の洗浄剤組成物全体に対する配合量が0.1~50質量%であり、上記成分(B)の洗浄剤組成物全体に対する配合量が0.01~10質量%である、第一の発明に記載の洗浄剤組成物である。 The second invention is the cleaning composition according to the first invention, in which the amount of component (A) in the entire cleaning composition is 0.1 to 50 mass %, and the amount of component (B) in the entire cleaning composition is 0.01 to 10 mass %.
本発明の洗浄剤組成物は、化粧料や汚れに対する十分な洗浄機能を有しながら皮膚刺激が低く、洗浄による肌のバリア機能低下を抑制することができる洗浄剤組成物を提供することができる。 The detergent composition of the present invention provides a detergent composition that has sufficient cleaning function against cosmetics and dirt, while causing low skin irritation and preventing a decrease in the skin's barrier function due to cleaning.
以下、本発明の構成について詳述する。本発明の洗浄剤組成物は、以下に詳述する成分(A)アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩を主成分として含有する活性剤化合物、及び(B)アミンオキシド型両性界面活性剤を含有することにより、本発明の効果を発揮することができる。以下、本発明の成分等を具体的に説明する。 The composition of the present invention will be described in detail below. The cleaning composition of the present invention can exhibit the effects of the present invention by containing the component (A) an activator compound containing an acyl isethionate and/or an acylalkyl isethionate as a main component, and (B) an amine oxide amphoteric surfactant, which are described in detail below. The components of the present invention will be described in detail below.
<成分(A) 活性剤化合物>
本発明の洗浄剤組成物で用いられる成分(A)は、アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩、並びにそれらの製造時の副生成物である脂肪酸及び/又は脂肪酸塩を含有する活性剤化合物である。本発明の成分(A)は、水を含まない成分(A)の総量に対して、アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩を80質量%以上含有する。本発明の成分(A)は、洗浄剤組成物の泡立ちの向上、増粘性の向上、さっぱり感の改善、ぬるつき感の低減のために加えられる。また本発明において、成分(A)は、適宜合成したものを用いてもよいし、市販品を用いてもよい。市販品としては、以下に限定されるものではないが、例えば、ISELUX SFS(Innospec Active Chemicals LLC社製)、PUREACT I-78(Innospec Active Chemicals LLC社製)、ISELUX(Innospec Active Chemicals LLC社製)、ダイヤポンCI(日油株式会社製)などを用いることができる。
<Component (A) Active Agent Compound>
The component (A) used in the detergent composition of the present invention is an activator compound containing acyl isethionate and/or acylalkyl isethionate, and fatty acid and/or fatty acid salt, which are by-products during the production thereof. The component (A) of the present invention contains 80 mass% or more of acyl isethionate and/or acylalkyl isethionate based on the total amount of the component (A) not including water. The component (A) of the present invention is added to improve the foaming of the detergent composition, improve the viscosity, improve the refreshing feeling, and reduce the sticky feeling. In the present invention, the component (A) may be appropriately synthesized or may be a commercially available product. Examples of commercially available products that can be used include, but are not limited to, ISELUX SFS (manufactured by Innospec Active Chemicals LLC), PUREACT I-78 (manufactured by Innospec Active Chemicals LLC), ISELUX (manufactured by Innospec Active Chemicals LLC), and Diapon CI (manufactured by NOF Corporation).
アシルイセチオン酸塩ないしアシルアルキルイセチオン酸塩は、脂肪酸石鹸、アルキル硫酸塩、アルキルエーテル硫酸塩等の他のアニオン性界面活性剤に比べて皮膚や粘膜に対する刺激性が低く、極めて温和な界面活性剤である。アシルイセチオン酸塩ないしアシルアルキルイセチオン酸塩は、石鹸に対し低温での泡立ち性の向上や使用後のごわごわとした感触の軽減を図ることができる。このようなアシルイセチオン酸塩ないしアシルアルキルイセチオン酸塩としては、ナトリウム塩が好ましい。 Acyl isethionate or acylalkyl isethionate is an extremely mild surfactant that is less irritating to the skin and mucous membranes than other anionic surfactants such as fatty acid soaps, alkyl sulfates, and alkyl ether sulfates. Acyl isethionate or acylalkyl isethionate can improve the lathering properties of soap at low temperatures and reduce the stiff feeling after use. As such acyl isethionate or acylalkyl isethionate, sodium salts are preferred.
一般的に、皮膚への刺激性を低減する観点からはアミノ酸系洗浄剤が好ましい。一方で、石鹸系の洗浄剤に比べてアミノ酸系の洗浄剤は皮膚への刺激性は低いが、泡立ち及び泡量は劣る傾向にある。そこで、皮膚への刺激を抑えながら泡立ちを改善するために、アシルイセチオン酸塩及び/又はアシルアルキルイセチオン酸塩を含有する活性剤組成物が用いられる。 In general, amino acid-based detergents are preferred from the viewpoint of reducing irritation to the skin. On the other hand, amino acid-based detergents are less irritating to the skin than soap-based detergents, but tend to have poorer foaming and foam volume. Therefore, in order to improve foaming while suppressing irritation to the skin, an activator composition containing acyl isethionate and/or acylalkyl isethionate is used.
しかしながら、アシルイセチオン酸塩やアシルアルキルイセチオン酸塩を、当該技術分野において通常知られている製造方法により製造する場合には、副生成物として不可避的に、未反応状態の脂肪酸及び脂肪酸塩が副生成物として最終反応混合物中に存在しており、それらの種々の脂肪酸塩のうち、特に脂肪酸組成中の比率の高いラウリン酸塩は皮膚への吸着性が高いことから、洗顔後の肌荒れなどの皮膚刺激性を引き起こす可能性がある。例えば、(A)成分がラウロイルメチルイセチオン酸ナトリウムである場合、これらを製造すると最終反応混合物中に不可避的に未反応物であるメチルイセチオン酸ナトリウムやラウリン酸ナトリウムやラウリン酸が存在している。 However, when acyl isethionate or acylalkyl isethionate is produced by a production method generally known in the art, unreacted fatty acids and fatty acid salts are inevitably present as by-products in the final reaction mixture, and among these various fatty acid salts, laurate salts, which have a particularly high ratio in the fatty acid composition, are highly adsorbed to the skin and may cause skin irritation such as rough skin after washing the face. For example, when component (A) is sodium lauroyl methyl isethionate, when it is produced, unreacted sodium methyl isethionate, sodium laurate, and lauric acid are inevitably present in the final reaction mixture.
そのため、アミノ酸系洗浄剤のような皮膚への刺激性の低い洗浄剤へ、泡立ちを改善するためにイセチオン酸系活性剤を添加する場合に、当該イセチオン酸系活性剤に不可避的に含有される副生成物によって肌荒れなどの皮膚刺激性を引き起こす可能性があった。 Therefore, when an isethionic acid-based surfactant is added to a cleaning agent with low skin irritation, such as an amino acid-based cleaning agent, in order to improve foaming, there is a possibility that the by-products inevitably contained in the isethionic acid-based surfactant may cause skin irritation, such as rough skin.
このような欠点を解消するために、本発明の洗浄剤組成物は、以下に詳述する成分(B)を上記成分(A)と組み合わせて用いることにより、各成分の相互作用によって相乗的に効果を発揮することができネガティブな影響を相殺することで改善することができる。したがって、本発明の洗浄剤組成物は、優れた泡立ちの早さ、洗いあがりのさっぱり感、マイルドな皮膚刺激、濃密でクリーミィなもっちりとした泡質を実現することができるため優れている。 To overcome these drawbacks, the detergent composition of the present invention uses component (B) described in detail below in combination with component (A) described above, which allows the interaction of the components to exert a synergistic effect and offset the negative effects, making it possible to improve the situation. Therefore, the detergent composition of the present invention is excellent because it can achieve excellent foaming speed, a refreshing feeling after washing, mild skin irritation, and a dense, creamy, and bouncy foam quality.
本発明において、成分(A)の配合量は本発明の効果を発揮するに限り特に限定されるものではないが、洗浄剤組成物全体に対して、好ましくは0.1~50質量%であり、より好ましくは5~30質量%である。成分(A)の配合量が0.1質量%以上であれば泡立ちが良好であり、50質量%以下であれば組成物の粘度が高くなり過ぎず低温でも硬くならないため好ましい。 In the present invention, the amount of component (A) is not particularly limited as long as the effect of the present invention is exhibited, but is preferably 0.1 to 50 mass %, and more preferably 5 to 30 mass %, of the entire cleaning composition. If the amount of component (A) is 0.1 mass % or more, good foaming is achieved, and if it is 50 mass % or less, the viscosity of the composition does not become too high and it does not harden even at low temperatures, so this is preferable.
<成分(B) アミンオキシド型両性界面活性剤>
本発明の洗浄剤組成物で用いられる成分(B)は、アミンオキシド型両性界面活性剤である。アミンオキシド型両性界面活性剤は、上記成分(A)の不可避的な副生成物に起因する洗浄剤組成物へのネガティブな影響を改善するために用いられる。本発明の成分(B)は、優れた洗浄力、起泡力を有する両性界面活性剤であり、洗浄剤組成物の使用感の改善や、石鹸系洗浄剤組成物特有の肌のきしみ感を改善することができる。アミンオキシド型両性界面活性剤の例としては、ラウリルジメチルアミンオキシド、ステアリルジメチルアミンオキシド、オレイルジメチルアミンオキシド、ジヒドロキシエチルラウリルアミンオキシド、ヤシ油アルキルジメチルアミンオキシド、ラウラミドプロピルアミンオキシド、ミリスタミドプロピルアミンオキシドなどが挙げられる。本発明において、成分(B)は市販のものを用いてもよく、これらに限定されるものではないが、具体的な製品として例えば、川研ファインケミカル社製の「ソフタゾリンLAO-C」や、花王社製の「アンヒトール20N」などが挙げられる。1種単独で用いてもよく、2種以上組み合わせて用いてもよい。中でも、バリア機能保持の観点からラウリルジメチルアミンオキシドを用いることが好ましい。
<Component (B): Amine oxide type amphoteric surfactant>
The component (B) used in the detergent composition of the present invention is an amine oxide type amphoteric surfactant. The amine oxide type amphoteric surfactant is used to improve the negative effects on the detergent composition caused by the unavoidable by-products of the above component (A). The component (B) of the present invention is an amphoteric surfactant having excellent detergency and foaming power, and can improve the feeling of use of the detergent composition and the squeaky feeling of the skin that is unique to soap-based detergent compositions. Examples of amine oxide type amphoteric surfactants include lauryl dimethylamine oxide, stearyl dimethylamine oxide, oleyl dimethylamine oxide, dihydroxyethyl laurylamine oxide, coconut oil alkyl dimethylamine oxide, lauramidopropylamine oxide, and myristamidopropylamine oxide. In the present invention, the component (B) may be a commercially available product, and is not limited thereto. Specific examples of the product include "Softazoline LAO-C" manufactured by Kawaken Fine Chemical Co., Ltd. and "Amphitol 20N" manufactured by Kao Corporation. One type may be used alone, or two or more types may be used in combination. Of these, it is preferable to use lauryl dimethylamine oxide from the viewpoint of maintaining the barrier function.
本発明において、成分(B)を上記成分(A)と組み合わせて用いることにより、上記
成分(A)による泡立ちの改善という良好な効果を発揮しながら、(A)成分に含まれる副生成物に起因するネガティブな影響を改善することができる。したがって、本発明において、成分(A)と成分(B)を組み合わせることにより、メイクアップ化粧料や顔の汚れに対する十分な洗浄機能を有しながらも、皮膚に対する刺激が低く、かつ洗浄による肌のバリア機能低下を抑制できる洗浄剤組成物とすることができる。
In the present invention, by using component (B) in combination with component (A), it is possible to improve the negative effects caused by by-products contained in component (A) while exerting the favorable effect of improving foaming caused by component (A). Therefore, in the present invention, by combining components (A) and (B), it is possible to obtain a cleanser composition that has a sufficient cleansing function against makeup cosmetics and facial dirt, while being low in irritation to the skin and capable of suppressing a decrease in the barrier function of the skin due to cleansing.
本発明において、成分(B)の配合量は本発明の効果を発揮するに限り特に限定されるものではないが、洗浄剤組成物全体に対して、好ましくは0.01~10質量%であり、より好ましくは0.1~10質量%である。0.01質量%以上であれば皮膚への刺激の緩和作用が十分に発揮され、10質量%以下であれば組成物の安定性が良好であるため好ましい。 In the present invention, the amount of component (B) is not particularly limited as long as the effect of the present invention is exhibited, but is preferably 0.01 to 10 mass %, and more preferably 0.1 to 10 mass %, based on the total cleansing composition. If it is 0.01 mass % or more, the effect of mitigating irritation to the skin is sufficiently exhibited, and if it is 10 mass % or less, the stability of the composition is good, so this is preferable.
<成分(C) 非イオン性界面活性剤>
本発明の洗浄剤組成物で用いられる成分(C)は、テトラグリセリンモノラウリルエーテル、ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタンモノラウリン酸エステルから選択される1以上の非イオン性界面活性剤である。非イオン性界面活性剤は、洗浄剤組成物の泡質及び洗浄力のさらなる向上のために用いられる。本発明の成分(C)は市販のものを用いてもよく、これらの限定されるものではないが、例えば、サンイーサーL-4(太陽化学株式会社製)、サンソフトM-12J(太陽化学株式会社製)、ノニオンLT-280(日油株式会社製)等を用いることができる。
<Component (C) Nonionic Surfactant>
The component (C) used in the detergent composition of the present invention is one or more nonionic surfactants selected from tetraglycerol monolauryl ether, polyglycerol fatty acid ester, and polyoxyethylene sorbitan monolaurate. The nonionic surfactant is used to further improve the foam quality and detergency of the detergent composition. The component (C) of the present invention may be a commercially available one, and is not limited thereto. For example, Sunether L-4 (manufactured by Taiyo Kagaku Co., Ltd.), Sunsoft M-12J (manufactured by Taiyo Kagaku Co., Ltd.), Nonion LT-280 (manufactured by NOF Corporation), etc. can be used.
<その他の成分>
本発明の洗浄剤組成物は、上述した成分の他に、本発明の目的を損なわない範囲で、その他の成分、例えば、上記界面活性剤以外の界面活性剤、炭化水素、エステル、高級アルコール、多価アルコール、油剤、粉体(顔料、色素、樹脂等)、水、防腐剤、香料、保湿剤、生理活性成分、塩類、溶媒、パール化剤、中和剤、pH調整剤、昆虫忌避剤、酵素等の成分を適宜配合することができる。
<Other ingredients>
In addition to the components described above, the cleaning composition of the present invention may contain other components as appropriate, provided such components do not impair the object of the present invention. For example, surfactants other than the above-mentioned surfactants, hydrocarbons, esters, higher alcohols, polyhydric alcohols, oils, powders (pigments, colorants, resins, etc.), water, preservatives, fragrances, moisturizers, physiologically active components, salts, solvents, pearlizing agents, neutralizing agents, pH adjusters, insect repellents, enzymes, and other components may be blended.
上記油剤は、通常化粧料に用いられる揮発性および不揮発性の油剤、溶剤および樹脂が挙げられ、常温で液体、ペースト、固体であっても構わないが、ハンドリングに優れる液体が好ましい。具体的に油剤としては、例えばセチルアルコール、イソステアリルアルコール、ラウリルアルコール、ヘキサデシルアルコール、オクチルドデカノール等の高級アルコール、イソステアリン酸、ウンデシレン酸、オレイン酸等の脂肪酸、ミリスチン酸ミリスチル、ラウリン酸ヘキシル、オレイン酸デシル、ミリスチン酸イソプロピル、ジメチルオクタン酸ヘキシルデシル、モノステアリン酸グリセリン、フタル酸ジエチル、モノステアリン酸エチレングリコール、オキシステアリン酸オクチル等のエステル類、流動パラフィン、ワセリン、スクワラン等の炭化水素、ラノリン、還元ラノリン、カルナバロウ等のロウ、ミンク油、カカオ油、ヤシ油、パーム核油、ツバキ油、ゴマ油、ヒマシ油、オリーブ油等の油脂などが挙げられる。また、シリコーン類として例えばジメチルポリシロキサン、メチルハイドロジェンポリシロキサン、メチルフェニルポリシロキサン、ポリエーテル変性オルガノポリシロキサン、フルオロアルキル・ポリオキシアルキレン共変性オルガノポリシロキサン、アルキル変性オルガノポリシロキサン、ジメチコノール、末端変性オルガノポリシロキサン、フッ素変性オルガノポリシロキサン、アモジメチコーン、アミノ変性オルガノポリシロキサン、シリコーンゲル、アクリルシリコーン、トリメチルシロキシケイ酸、シリコーンRTVゴム、フッ素変性シリコーン樹脂等のシリコーン化合物が挙げられる。 The oils mentioned above include volatile and non-volatile oils, solvents and resins that are usually used in cosmetics, and may be liquid, paste or solid at room temperature, but liquids that are easy to handle are preferred. Specific examples of oils include higher alcohols such as cetyl alcohol, isostearyl alcohol, lauryl alcohol, hexadecyl alcohol and octyldodecanol, fatty acids such as isostearic acid, undecylenic acid and oleic acid, esters such as myristyl myristate, hexyl laurate, decyl oleate, isopropyl myristate, hexyldecyl dimethyloctanoate, glycerin monostearate, diethyl phthalate, ethylene glycol monostearate and octyl oxystearate, hydrocarbons such as liquid paraffin, petrolatum and squalane, waxes such as lanolin, reduced lanolin and carnauba wax, and oils and fats such as mink oil, cacao oil, coconut oil, palm kernel oil, camellia oil, sesame oil, castor oil and olive oil. Examples of silicones include silicone compounds such as dimethylpolysiloxane, methylhydrogenpolysiloxane, methylphenylpolysiloxane, polyether-modified organopolysiloxane, fluoroalkyl-polyoxyalkylene-co-modified organopolysiloxane, alkyl-modified organopolysiloxane, dimethiconol, terminal-modified organopolysiloxane, fluorine-modified organopolysiloxane, amodimethicone, amino-modified organopolysiloxane, silicone gel, acrylic silicone, trimethylsiloxysilicate, silicone RTV rubber, and fluorine-modified silicone resin.
上記粉体としては、例えば赤色201号、黄色4号、青色1号、黒色401号等の色素、黄色4号A1レーキ、黄色203号Baレーキ等のレーキ色素、ナイロンパウダー、シルクパウダー、シリコーンパウダー、セルロースパウダー、シリコーンエラストマー球状
粉体、ポリエチレン末等の高分子、黄酸化鉄、赤色酸化鉄、酸化クロム、カーボンブラック、群青、紺青等の有色顔料、酸化亜鉛、酸化チタン等の白色顔料、タルク、マイカ、セリサイト、カオリン等の体質顔料、雲母チタン等のパール顔料、硫酸バリウム、炭酸カルシウム、炭酸マグネシウム、珪酸マグネシウム等の金属塩、シリカ、アルミナ等の無機粉体、ベントナイト、スメクタイト、窒化ホウ素等が挙げられる。これらの粉体の形状(球状、棒状、針状、板状、不定形状、燐片状、紡錘状等)に特に制限はない。
Examples of the powder include pigments such as Red No. 201, Yellow No. 4, Blue No. 1, and Black No. 401, lake pigments such as Yellow No. 4 A1 Lake and Yellow No. 203 Ba Lake, nylon powder, silk powder, silicone powder, cellulose powder, spherical silicone elastomer powder, polymers such as polyethylene powder, colored pigments such as yellow iron oxide, red iron oxide, chromium oxide, carbon black, ultramarine, and Prussian blue, white pigments such as zinc oxide and titanium oxide, extender pigments such as talc, mica, sericite, and kaolin, pearl pigments such as titanium mica, metal salts such as barium sulfate, calcium carbonate, magnesium carbonate, and magnesium silicate, inorganic powders such as silica and alumina, bentonite, smectite, and boron nitride. There are no particular limitations on the shape of these powders (spherical, rod-like, needle-like, plate-like, irregular, flaky, spindle-like, etc.).
上記粉体は、従来公知の表面処理、例えばフッ素化合物処理、シリコーン処理、シリコーン樹脂処理、ペンダント処理、シランカップリング剤処理、チタンカップリング剤処理、油剤処理、N-アシル化リジン処理、ポリアクリル酸処理、金属石けん処理、アミノ酸処理、無機化合物処理、プラズマ処理、メカノケミカル処理等によって事前に表面処理されていてもいなくても構わない。 The powder may or may not have been previously surface-treated by a conventional surface treatment such as a fluorine compound treatment, silicone treatment, silicone resin treatment, pendant treatment, silane coupling agent treatment, titanium coupling agent treatment, oil treatment, N-acylated lysine treatment, polyacrylic acid treatment, metal soap treatment, amino acid treatment, inorganic compound treatment, plasma treatment, mechanochemical treatment, etc.
上記溶媒としては、例えば精製水、エタノール、軽質流動イソパラフィン、低級アルコール、エーテル類、LPG、フルオロカーボン、N-メチルピロリドン、フルオロアルコール、揮発性直鎖状シリコーン、次世代フロン等が挙げられる。 Examples of the above solvents include purified water, ethanol, light liquid isoparaffin, lower alcohols, ethers, LPG, fluorocarbons, N-methylpyrrolidone, fluoroalcohols, volatile linear silicones, next-generation fluorocarbons, etc.
上記生理活性成分としては、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質が挙げられる。例えば、抗炎症剤、老化防止剤、紫外線防御剤、ひきしめ剤、抗酸化剤、保湿剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン剤、アミノ酸、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。上記生理活性成分は、天然系の植物抽出成分、乾燥抽出成分、生薬成分や、化合物等が挙げられるが、これらの中でも、特に天然系の植物抽出成分、海藻抽出成分、生薬成分が安全性の点で好ましい。 The above-mentioned physiologically active ingredients include substances that impart some kind of physiological activity to the skin when applied to the skin. Examples include anti-inflammatory agents, anti-aging agents, UV protection agents, tightening agents, antioxidants, moisturizing agents, blood circulation promoters, antibacterial agents, bactericides, drying agents, cooling agents, warming agents, vitamins, amino acids, wound healing promoters, irritation relief agents, analgesics, cell activators, enzyme components, etc. The above-mentioned physiologically active ingredients include natural plant extracts, dried extracts, herbal ingredients, compounds, etc., of which natural plant extracts, seaweed extracts, and herbal ingredients are particularly preferred from the standpoint of safety.
上記天然系の植物抽出成分、海藻抽出成分、生薬成分の例としては、例えばアシタバエキス、アマチャエキス、アルテアエキス、アロエエキス、アンズエキス、イチョウエキス、ウイキョウエキス、ウーロン茶エキス、エイジツエキス、オウゴンエキス、オウバクエキス、オトギリソウエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、加水分解コムギ末、加水分解シルク、カモミラエキス、カロットエキス、カワラヨモギエキス、甘草エキス、カキョクエキス、キウイエキス、キューカンバーエキス、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、グレープフルーツエキス、クロレラエキス、クワエキス、紅茶エキス、酵母エキス、コラーゲン、サルビアエキス、サボンソウエキス、サンザシエキス、ジオウエキス、シコンエキス、シソエキス、シナノキエキス、シャクヤクエキス、シラカバエキス、スギナエキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、センキュウエキス、センブリエキス、タイソウエキス、タイムエキス、茶エキス、チョウジエキス、チンピエキス、トウキエキス、トウニンエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、蜂蜜、ハマメリスエキス、ヒキオコシエキス、ビサボロール、ビワエキス、ブクリョウエキス、プロポリス、ヘチマエキス、ペパーミントエキス、ボダイジュエキス、ホップエキス、マロニエエキス、ムクロジエキス、メリッサエキス、モモエキス、ユキノシタエキス、ユズエキス、ヨモギエキス、ラベンダーエキス、レモンエキス、レンゲソウエキス、ローズマリーエキス、ローヤルゼリーエキス等を挙げることができる。 Examples of the above-mentioned natural plant extracts, seaweed extracts, and herbal medicines include angelica tree extract, amacha extract, althea extract, aloe extract, apricot extract, ginkgo extract, fennel extract, oolong tea extract, angelica tree extract, scutellaria extract, phellodendron bark extract, hypericum extract, watercress extract, orange extract, seawater dried product, seaweed extract, hydrolyzed wheat powder, hydrolyzed silk, chamomile extract, carrot extract, artemisia capillaris extract, licorice extract, kakyoku extract, kiwi extract, cucumber extract, gardenia extract, kumazasa extract, sophora flavescens extract, walnut extract, grapefruit extract, chlorella extract, mulberry extract, black tea extract, yeast extract, collagen, salvia extract, soapwort extract, hawthorn extract, rehmannia extract, lithospermum extract, perilla extract, linden extract, peony extract, and white gnats. Examples of such extracts include Japanese whiting, horsetail extract, ivy extract, hawthorn extract, elderberry extract, yarrow extract, peppermint extract, sage extract, cnidium rhizome extract, swertia britannica extract, taiso extract, thyme extract, tea extract, clove extract, tangerine peel extract, angelica extract, peach kernel extract, dokudami extract, tomato extract, natto extract, carrot extract, garlic extract, wild rose extract, honey, witch hazel extract, Japanese knotweed extract, bisabolol, loquat extract, poria extract, propolis, loofah extract, peppermint extract, linden extract, hop extract, horse chestnut extract, soapberry extract, melissa extract, peach extract, saxifrage extract, yuzu extract, mugwort extract, lavender extract, lemon extract, astragalus extract, rosemary extract, and royal jelly extract.
また、上記天然系の植物抽出成分、海藻抽出成分、生薬成分以外の成分としては、例えばデオキシリボ核酸、ムコ多糖類、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、キチン、キトサン、加水分解卵殻膜などの生体高分子、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム、ベタイン、ホエイ等の保湿成分、スフィンゴ脂質、セラミド、コレステロール、コレステロール誘導体、リ
ン脂質等の油性成分、ε-アミノカプロン酸、グリチルリチン酸、β-グリチルレチン酸、塩化リゾチーム、グアイアズレン、ヒドロコルチゾン等の抗炎症剤、ビタミン類(A、B2、B6、C、D、E)、パントテン酸カルシウム、ビオチン、ニコチン酸アミド、ビタミンCエステル等のビタミン類、アラントイン、ジイソプロピルアミンジクロロアセテート、4-アミノメチルシクロヘキサンカルボン酸等の活性成分、トコフェロール、カロチノイド、フラボノイド、タンニン、リグナン、サポニン等の抗酸化剤、α-ヒドロキシ酸、β-ヒドロキシ酸等の細胞賦活剤、γ-オリザノール、ビタミンE誘導体等の血行促進剤、イソピロピルメチルフェノール、トリクロサン、ヒノキチオール、塩化ベンザルコニウム等の殺菌剤、1-メントール、ハッカ油等の冷感剤、レチノール、レチノール誘導体等の創傷治癒剤等が挙げられる。上記油剤は、通常化粧料に用いられる揮発性および不揮発性の油剤、溶剤および樹脂が挙げられ、常温で液体、ペースト、固体であっても構わないが、ハンドリングに優れる液体が好ましい。具体的に油剤としては、例えばセチルアルコール、イソステアリルアルコール、ラウリルアルコール、ヘキサデシルアルコール、オクチルドデカノール等の高級アルコール、イソステアリン酸、ウンデシレン酸、オレイン酸等の脂肪酸、ミリスチン酸ミリスチル、ラウリン酸ヘキシル、オレイン酸デシル、ミリスチン酸イソプロピル、ジメチルオクタン酸ヘキシルデシル、モノステアリン酸グリセリン、フタル酸ジエチル、モノステアリン酸エチレングリコール、オキシステアリン酸オクチル等のエステル類、流動パラフィン、ワセリン、スクワラン等の炭化水素、ラノリン、還元ラノリン、カルナバロウ等のロウ、ミンク油、カカオ油、ヤシ油、パーム核油、ツバキ油、ゴマ油、ヒマシ油、オリーブ油等の油脂などが挙げられる。また、シリコーン類として例えばジメチルポリシロキサン、メチルハイドロジェンポリシロキサン、メチルフェニルポリシロキサン、ポリエーテル変性オルガノポリシロキサン、フルオロアルキル・ポリオキシアルキレン共変性オルガノポリシロキサン、アルキル変性オルガノポリシロキサン、ジメチコノール、末端変性オルガノポリシロキサン、フッ素変性オルガノポリシロキサン、アモジメチコーン、アミノ変性オルガノポリシロキサン、シリコーンゲル、アクリルシリコーン、トリメチルシロキシケイ酸、シリコーンRTVゴム、フッ素変性シリコーン樹脂等のシリコーン化合物が挙げられる。
In addition, examples of ingredients other than the above-mentioned natural plant extract ingredients, seaweed extract ingredients, and herbal medicine ingredients include biopolymers such as deoxyribonucleic acid, mucopolysaccharides, sodium hyaluronate, sodium chondroitin sulfate, collagen, elastin, chitin, chitosan, and hydrolyzed eggshell membrane, moisturizing ingredients such as amino acids, sodium lactate, urea, sodium pyrrolidone carboxylate, betaine, and whey, oily ingredients such as sphingolipids, ceramide, cholesterol, cholesterol derivatives, and phospholipids, anti-inflammatory agents such as ε-aminocaproic acid, glycyrrhizic acid, β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, and hydrocortisone, vitamins (A, B2, B6, C, D, E), vitamins such as calcium pantothenate, biotin, nicotinamide, vitamin C ester, active ingredients such as allantoin, diisopropylamine dichloroacetate, 4-aminomethylcyclohexanecarboxylic acid, antioxidants such as tocopherol, carotenoids, flavonoids, tannins, lignans, saponins, cell activators such as α-hydroxy acids, β-hydroxy acids, blood circulation promoters such as γ-oryzanol, vitamin E derivatives, bactericides such as isopropylmethylphenol, triclosan, hinokitiol, benzalkonium chloride, cooling agents such as 1-menthol, peppermint oil, wound healing agents such as retinol, retinol derivatives, etc. The oils mentioned above include volatile and non-volatile oils, solvents and resins that are usually used in cosmetics, and may be liquids, pastes or solids at room temperature, but liquids that are easy to handle are preferred. Specific examples of the oil agent include higher alcohols such as cetyl alcohol, isostearyl alcohol, lauryl alcohol, hexadecyl alcohol, and octyldodecanol; fatty acids such as isostearic acid, undecylenic acid, and oleic acid; esters such as myristyl myristate, hexyl laurate, decyl oleate, isopropyl myristate, hexyldecyl dimethyloctanoate, glycerin monostearate, diethyl phthalate, ethylene glycol monostearate, and octyl oxystearate; hydrocarbons such as liquid paraffin, petrolatum, and squalane; waxes such as lanolin, reduced lanolin, and carnauba wax; and oils and fats such as mink oil, cacao oil, coconut oil, palm kernel oil, camellia oil, sesame oil, castor oil, and olive oil. Further, examples of silicones include silicone compounds such as dimethylpolysiloxane, methylhydrogenpolysiloxane, methylphenylpolysiloxane, polyether-modified organopolysiloxane, fluoroalkyl-polyoxyalkylene-co-modified organopolysiloxane, alkyl-modified organopolysiloxane, dimethiconol, terminal-modified organopolysiloxane, fluorine-modified organopolysiloxane, amodimethicone, amino-modified organopolysiloxane, silicone gel, acrylic silicone, trimethylsiloxysilicate, silicone RTV rubber, and fluorine-modified silicone resin.
また、上記粉体としては、例えば赤色201号、黄色4号、青色1号、黒色401号等の色素、黄色4号A1レーキ、黄色203号Baレーキ等のレーキ色素、ナイロンパウダー、シルクパウダー、シリコーンパウダー、セルロースパウダー、シリコーンエラストマー球状粉体、ポリエチレン末等の高分子、黄酸化鉄、赤色酸化鉄、酸化クロム、カーボンブラック、群青、紺青等の有色顔料、酸化亜鉛、酸化チタン等の白色顔料、タルク、マイカ、セリサイト、カオリン等の体質顔料、雲母チタン等のパール顔料、硫酸バリウム、炭酸カルシウム、炭酸マグネシウム、珪酸マグネシウム等の金属塩、シリカ、アルミナ等の無機粉体、ベントナイト、スメクタイト、窒化ホウ素等が挙げられる。これらの粉体の形状(球状、棒状、針状、板状、不定形状、燐片状、紡錘状等)に特に制限はない。 The above powders include, for example, pigments such as Red No. 201, Yellow No. 4, Blue No. 1, and Black No. 401; lake pigments such as Yellow No. 4 A1 Lake and Yellow No. 203 Ba Lake; nylon powder, silk powder, silicone powder, cellulose powder, spherical silicone elastomer powder, polymers such as polyethylene powder, colored pigments such as yellow iron oxide, red iron oxide, chromium oxide, carbon black, ultramarine, and Prussian blue; white pigments such as zinc oxide and titanium oxide; extender pigments such as talc, mica, sericite, and kaolin; pearl pigments such as titanium mica; metal salts such as barium sulfate, calcium carbonate, magnesium carbonate, and magnesium silicate; inorganic powders such as silica and alumina; bentonite, smectite, and boron nitride. There are no particular limitations on the shape of these powders (spherical, rod-like, needle-like, plate-like, irregular, flaky, spindle-like, etc.).
上記粉体は、従来公知の表面処理、例えばフッ素化合物処理、シリコーン処理、シリコーン樹脂処理、ペンダント処理、シランカップリング剤処理、チタンカップリング剤処理、油剤処理、N-アシル化リジン処理、ポリアクリル酸処理、金属石けん処理、アミノ酸処理、無機化合物処理、プラズマ処理、メカノケミカル処理等によって事前に表面処理されていてもいなくても構わない。 The powder may or may not have been previously surface-treated by conventional surface treatments such as fluorine compound treatment, silicone treatment, silicone resin treatment, pendant treatment, silane coupling agent treatment, titanium coupling agent treatment, oil treatment, N-acylated lysine treatment, polyacrylic acid treatment, metal soap treatment, amino acid treatment, inorganic compound treatment, plasma treatment, mechanochemical treatment, etc.
上記溶媒としては、例えば精製水、エタノール、軽質流動イソパラフィン、低級アルコール、エーテル類、LPG、フルオロカーボン、N-メチルピロリドン、フルオロアルコール、揮発性直鎖状シリコーン、次世代フロン等が挙げられる。 Examples of the above solvents include purified water, ethanol, light liquid isoparaffin, lower alcohols, ethers, LPG, fluorocarbons, N-methylpyrrolidone, fluoroalcohols, volatile linear silicones, next-generation fluorocarbons, etc.
上記生理活性成分としては、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質が挙げられる。例えば、抗炎症剤、老化防止剤、紫外線防御剤、ひきしめ剤、抗酸化剤、
保湿剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン剤、アミノ酸、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。上記生理活性成分は、天然系の植物抽出成分、乾燥抽出成分、生薬成分や、化合物等が挙げられるが、これらの中でも、特に天然系の植物抽出成分、海藻抽出成分、生薬成分が安全性の点で好ましい。
The above-mentioned physiologically active ingredients include substances that impart some physiological activity to the skin when applied to the skin. For example, anti-inflammatory agents, anti-aging agents, UV protection agents, firming agents, antioxidants,
Examples of the physiologically active ingredient include moisturizing agents, blood circulation promoters, antibacterial agents, disinfectants, drying agents, cooling agents, warming agents, vitamins, amino acids, wound healing promoters, irritation mitigating agents, analgesics, cell activators, enzyme components, etc. Examples of the physiologically active ingredient include natural plant extracts, dried extracts, herbal ingredients, compounds, etc., and among these, natural plant extracts, seaweed extracts, and herbal ingredients are particularly preferred in terms of safety.
上記天然系の植物抽出成分、海藻抽出成分、生薬成分の例としては、例えばアシタバエキス、アマチャエキス、アルテアエキス、アロエエキス、アンズエキス、イチョウエキス、ウイキョウエキス、ウーロン茶エキス、エイジツエキス、オウゴンエキス、オウバクエキス、オトギリソウエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、加水分解コムギ末、加水分解シルク、カモミラエキス、カロットエキス、カワラヨモギエキス、甘草エキス、カキョクエキス、キウイエキス、キューカンバーエキス、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、グレープフルーツエキス、クロレラエキス、クワエキス、紅茶エキス、酵母エキス、コラーゲン、サルビアエキス、サボンソウエキス、サンザシエキス、ジオウエキス、シコンエキス、シソエキス、シナノキエキス、シャクヤクエキス、シラカバエキス、スギナエキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、センキュウエキス、センブリエキス、タイソウエキス、タイムエキス、茶エキス、チョウジエキス、チンピエキス、トウキエキス、トウニンエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、蜂蜜、ハマメリスエキス、ヒキオコシエキス、ビサボロール、ビワエキス、ブクリョウエキス、プロポリス、ヘチマエキス、ペパーミントエキス、ボダイジュエキス、ホップエキス、マロニエエキス、ムクロジエキス、メリッサエキス、モモエキス、ユキノシタエキス、ユズエキス、ヨモギエキス、ラベンダーエキス、レモンエキス、レンゲソウエキス、ローズマリーエキス、ローヤルゼリーエキス等を挙げることができる。 Examples of the above-mentioned natural plant extracts, seaweed extracts, and herbal medicine ingredients include, for example, angelica extract, amacha extract, althea extract, aloe extract, apricot extract, ginkgo extract, fennel extract, oolong tea extract, angelica tree extract, scutellaria extract, phellodendron bark extract, hypericum extract, Dutch mustard extract, orange extract, seawater dried product, seaweed extract, hydrolyzed wheat powder, hydrolyzed silk, chamomile extract, carrot extract, artemisia capillaris extract, licorice extract, kakyoku extract, kiwi extract, cucumber extract, gardenia extract, kumazasa extract, sophora flavescens extract, walnut extract, grapefruit extract, chlorella extract, mulberry extract, black tea extract, yeast extract, collagen, salvia extract, soapwort extract, hawthorn extract, rehmannia extract, lithospermum extract, perilla extract, linden extract, peony extract, and white gnats. Examples of such extracts include Japanese whiting, horsetail extract, ivy extract, hawthorn extract, elderberry extract, yarrow extract, peppermint extract, sage extract, cnidium rhizome extract, swertia britannica extract, taiso extract, thyme extract, tea extract, clove extract, tangerine peel extract, angelica extract, peach kernel extract, dokudami extract, tomato extract, natto extract, carrot extract, garlic extract, wild rose extract, honey, witch hazel extract, Japanese knotweed extract, bisabolol, loquat extract, poria extract, propolis, loofah extract, peppermint extract, linden extract, hop extract, horse chestnut extract, soapberry extract, melissa extract, peach extract, saxifrage extract, yuzu extract, mugwort extract, lavender extract, lemon extract, astragalus extract, rosemary extract, and royal jelly extract.
また、上記天然系の植物抽出成分、海藻抽出成分、生薬成分以外の成分としては、例えばデオキシリボ核酸、ムコ多糖類、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、キチン、キトサン、加水分解卵殻膜などの生体高分子、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム、ベタイン、ホエイ等の保湿成分、スフィンゴ脂質、セラミド、コレステロール、コレステロール誘導体、リン脂質等の油性成分、ε-アミノカプロン酸、グリチルリチン酸、β-グリチルレチン酸、塩化リゾチーム、グアイアズレン、ヒドロコルチゾン等の抗炎症剤、ビタミン類(A、B2、B6、C、D、E)、パントテン酸カルシウム、ビオチン、ニコチン酸アミド、ビタミンCエステル等のビタミン類、アラントイン、ジイソプロピルアミンジクロロアセテート、4-アミノメチルシクロヘキサンカルボン酸等の活性成分、トコフェロール、カロチノイド、フラボノイド、タンニン、リグナン、サポニン等の抗酸化剤、α-ヒドロキシ酸、β-ヒドロキシ酸等の細胞賦活剤、γ-オリザノール、ビタミンE誘導体等の血行促進剤、イソピロピルメチルフェノール、トリクロサン、ヒノキチオール、塩化ベンザルコニウム等の殺菌剤、1-メントール、ハッカ油等の冷感剤、レチノール、レチノール誘導体等の創傷治癒剤等が挙げられる。 In addition, ingredients other than the above-mentioned natural plant extract ingredients, seaweed extract ingredients, and herbal ingredients include, for example, biopolymers such as deoxyribonucleic acid, mucopolysaccharides, sodium hyaluronate, sodium chondroitin sulfate, collagen, elastin, chitin, chitosan, and hydrolyzed eggshell membrane, moisturizing ingredients such as amino acids, sodium lactate, urea, sodium pyrrolidone carboxylate, betaine, and whey, oily ingredients such as sphingolipids, ceramide, cholesterol, cholesterol derivatives, and phospholipids, anti-inflammatory agents such as ε-aminocaproic acid, glycyrrhizic acid, β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, and hydrocortisone, vitamins (A, B2, B6, C, D, E), vitamins such as calcium pantothenate, biotin, nicotinamide, vitamin C ester, active ingredients such as allantoin, diisopropylamine dichloroacetate, 4-aminomethylcyclohexanecarboxylic acid, antioxidants such as tocopherol, carotenoids, flavonoids, tannins, lignans, saponins, cell activators such as α-hydroxy acids and β-hydroxy acids, blood circulation promoters such as γ-oryzanol and vitamin E derivatives, bactericides such as isopropylmethylphenol, triclosan, hinokitiol, and benzalkonium chloride, cooling agents such as 1-menthol and peppermint oil, and wound healing agents such as retinol and retinol derivatives.
<洗浄剤組成物>
本発明の洗浄剤組成物は、常法に従って製造することができる。また、本発明の洗浄剤組成物の一例としては、洗顔フォーム、ボディソープ、クレンジング剤等が挙げられる。剤形は目的に応じて任意に選択することができる。すなわち、液状、クリーム状、ジェル状、乳液状、エアゾール状等のものが挙げられる。
<Cleaning agent composition>
The detergent composition of the present invention can be produced according to a conventional method. Examples of the detergent composition of the present invention include face wash foam, body soap, cleansing agent, etc. The dosage form can be selected arbitrarily depending on the purpose. That is, examples include liquid, cream, gel, emulsion, aerosol, etc.
次に本発明を実施例に基づいて詳細に説明するが、これに限定されるものではない。実施
例に先立ち、各実施例で採用した試験法、評価法を説明する。
The present invention will now be described in detail with reference to examples, but is not limited thereto. Prior to the examples, the test and evaluation methods employed in each example will be described.
実施例1~11、比較例1~3
(試料の調製)
下表1に示す組成の洗浄剤組成物を常法により調製した。
以下、本発明を実施例に基づいて更に詳細に説明するが、本発明はこれらの実施例によってなんら限定されるものではない。また、実施例および比較例における洗浄剤組成物の評価方法は以下のとおりであり、各成分の配合量は、特記しない限り「質量%」を表す。
Examples 1 to 11, Comparative Examples 1 to 3
(Sample Preparation)
A cleaning composition having the composition shown in Table 1 below was prepared by a conventional method.
The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. The methods for evaluating the cleaning compositions in the examples and comparative examples are as follows, and the blending amounts of each component are expressed in "mass %" unless otherwise specified.
(評価方法1:バリア保持能評価)
男女10名の専門パネルが、下表1に記載する洗浄剤組成物を2週間使用し、使用前と使用後において顔頬部の水分量をCorneometer CM825(Courage +Khazaka社製)により測定した。
<バリア保持能値>
バリア保持能値=(洗浄剤組成物を2週間使用した後の顔頬部の水分量)÷(洗浄剤組成物を使用前の顔頬部の水分量)
<判定基準>
上記のようにして算出したバリア保持能値が1.1を超えれば、洗浄剤組成物の使用により角質バリア機能が保持され、肌の状態が向上していると判定した。
(Evaluation method 1: Barrier retention ability evaluation)
A panel of 10 men and women used the cleansing compositions shown in Table 1 below for two weeks, and the moisture content of the face and cheeks was measured before and after use using a Corneometer CM825 (manufactured by Courage + Khazaka).
<Barrier retention value>
Barrier retention ability value=(amount of moisture on the face and cheeks after using the cleansing composition for 2 weeks)÷(amount of moisture on the face and cheeks before using the cleansing composition)
<Criteria>
If the barrier retention value calculated as described above exceeded 1.1, it was determined that the stratum corneum barrier function was maintained and skin condition was improved by use of the cleansing composition.
(評価方法2:刺激性評価)
敏感肌だと感じる20名の専門パネルにより、実施例及び比較例の洗浄剤組成物を使用し、刺激性について、下記の評価基準に従って官能評価した。なお、刺激感とは、洗浄直後から10分後までに感じる一時的なピリピリ感を言う。
<評価基準>
◎ : 20名中16名以上が、刺激感がないと回答
○ : 20名中11~15名が、刺激感がないと回答
△ : 20名中6~10名が、刺激感がないと回答
× : 20名中5名以下が、刺激感がないと回答
(Evaluation method 2: Irritation evaluation)
A panel of 20 experts with sensitive skin used the cleansing compositions of the Examples and Comparative Examples and evaluated their irritation according to the following criteria: The irritation sensation refers to a temporary tingling sensation felt immediately after cleansing and up to 10 minutes later.
<Evaluation criteria>
◎: 16 or more out of 20 people answered that there was no irritation. ○: 11 to 15 out of 20 people answered that there was no irritation. △: 6 to 10 out of 20 people answered that there was no irritation. ×: 5 or less out of 20 people answered that there was no irritation.
(評価方法3:泡立ち・泡量評価)
10名の専門パネルにより、実施例及び比較例の洗浄剤組成物を使用し、泡立ち・泡量について、下記の評価基準に従って官能評価した。
<評価基準>
◎ : 極めて良好 泡立ちが速く泡量が多いと答えた被験者の数が8人以上
○ : 良好 泡立ちが速く泡量が多いと答えた被験者の数が6人以上、8人未満
△ : やや悪い 泡立ちが速く泡量が多いと答えた被験者の数が4人以上、6人未満
× : 悪い 泡立ちが速く泡量が多いと答えた被験者の数が4人未満
(Evaluation method 3: Foaming and foam volume evaluation)
A panel of 10 experts used the cleaning compositions of the Examples and Comparative Examples and performed a sensory evaluation of foaming and foam volume in accordance with the following evaluation criteria.
<Evaluation criteria>
◎: Very good The number of subjects who answered that the foam is quick and has a lot of foam is 8 or more. ○: Good The number of subjects who answered that the foam is quick and has a lot of foam is 6 or more but less than 8. △: Somewhat poor The number of subjects who answered that the foam is quick and has a lot of foam is 4 or more but less than 6. ×: Poor The number of subjects who answered that the foam is quick and has a lot of foam is less than 4.
(評価方法4:保存安定性評価)
試料を50℃の恒温槽において30日間保管し、界面活性剤の析出及び相分離の有無を目視で観察し、以下の基準に従って保存安定性を評価した。
<評価基準>
○ : 30日間保管しても界面活性剤が析出せず、相分離も生じなかった
△ : 30日経過後には、界面活性剤が析出しており、相分離が見られた
× : 洗浄剤組成物の調製直後に界面活性剤が析出し、相分離が生じた
(Evaluation method 4: Storage stability evaluation)
The sample was stored in a thermostatic chamber at 50° C. for 30 days, and the presence or absence of precipitation of the surfactant and phase separation was visually observed, and the storage stability was evaluated according to the following criteria.
<Evaluation criteria>
◯: The surfactant did not precipitate and no phase separation occurred even after storage for 30 days. △: The surfactant precipitated and phase separation was observed after 30 days. ×: The surfactant precipitated and phase separation occurred immediately after preparation of the cleaning composition.
(評価結果)
実施例1~11および比較例1~3の組成および評価結果を下表1に示す。
The compositions and evaluation results of Examples 1 to 11 and Comparative Examples 1 to 3 are shown in Table 1 below.
実施例および比較例で用いた成分(A)の詳細を以下に示す。
(※1)ダイヤポンCI(日油株式会社製)
(※2)ISELUX(Innospec Active Chemicals LLC社製)
Details of the component (A) used in the examples and comparative examples are shown below.
(*1) Diapon CI (manufactured by NOF Corporation)
(*2) ISELUX (Innospec Active Chemicals LLC)
表1より明らかなように、本発明に係る実施例1~11の洗浄剤組成物は、比較例1~3の洗浄剤組成物に比べていずれも泡性能及び安定性が高く、さらに刺激性を有することもなく、肌のバリア保持能を向上させていた。 As is clear from Table 1, the cleaning compositions of Examples 1 to 11 according to the present invention all had higher foaming performance and stability than the cleaning compositions of Comparative Examples 1 to 3, and furthermore, they were not irritating and improved the skin barrier retention ability.
以下本発明の洗浄剤組成物のその他の処方例1~3を以下に記載する。これらの処方例の洗浄剤組成物を常法により調製し、上記実施例と同様に、肌のバリア保持能、刺激性、泡立ち・泡量及び保存安定性を評価したところ、いずれも実施例と同様に優れた性能を示した。 Other formulation examples 1 to 3 of the cleansing composition of the present invention are described below. The cleansing compositions of these formulation examples were prepared by conventional methods, and evaluated in the same manner as in the above examples for skin barrier retention ability, irritation, foaming/foam volume, and storage stability. All of these showed excellent performance, similar to the examples.
処方例1 泡吐出型フェイスウォッシュ 配合量(質量%)
ラウロイルメチルイセチオン酸Naを主とする原料(ISELUX) 10.0
ラウロイルメチルアラニンNa 8.0
ラウリルジメチルアミンオキシド 0.5
ラウリン酸PEG-80ソルビタン 2.0
ラウリン酸ポリグリセリル-10 1.0
グリセリン 5.0
ポリクオタニウム-7 0.1
フェノキシエタノール 0.2
EDTA-2Na 0.05
クエン酸 適量
香料 適量
精製水 残余
Formulation Example 1 Foam-type face wash Blend amount (mass%)
Raw material mainly consisting of sodium lauroyl methyl isethionate (ISELUX) 10.0
Sodium lauroyl methylalanine 8.0
Lauryl dimethylamine oxide 0.5
PEG-80 Sorbitan Laurate 2.0
Polyglyceryl-10 Laurate 1.0
Glycerin 5.0
Polyquaternium-7 0.1
Phenoxyethanol 0.2
EDTA-2Na 0.05
Citric acid, appropriate amount Flavoring, appropriate amount Purified water, balance
処方例2 ボディウォッシュ 配合量(質量%)
ラウロイルメチルイセチオン酸Naを主とする原料(ISELUX) 10.0
ラウロイルアスパラギン酸Na 10.0
ココイルグリシンK 5.0
ラウロイルメチルアラニンNa 2.0
ラウリルジメチルアミンオキシド 1.0
塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体 0.5
シア脂 0.5
セラミド2 0.5
セラミド5 0.5
ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル) 0.5
ポリクオタニウム-67 0.1
N-アセチルグルコサミン 0.5
ヒアルロン酸Na 0.5
DPG 0.5
グリセリン 5.0
フェノキシエタノール 0.2
EDTA-2Na 0.05
クエン酸 適量
香料 適量
精製水 残余
Formulation Example 2 Body wash Blend amount (mass%)
Raw material mainly consisting of sodium lauroyl methyl isethionate (ISELUX) 10.0
Sodium lauroyl aspartate 10.0
Cocoyl glycine K 5.0
Sodium Lauroyl Methylalanine 2.0
Lauryl dimethylamine oxide 1.0
Dimethyldiallylammonium chloride/acrylamide copolymer 0.5
Shea butter 0.5
Ceramide 2 0.5
Ceramide 5 0.5
Lauroyl glutamate di(phytosteryl/octyldodecyl) 0.5
Polyquaternium-67 0.1
N-acetylglucosamine 0.5
Sodium hyaluronate 0.5
DPG 0.5
Glycerin 5.0
Phenoxyethanol 0.2
EDTA-2Na 0.05
Citric acid, appropriate amount Flavoring, appropriate amount Purified water, balance
処方例3 洗顔フォーム 配合量(質量%)
ラウロイルメチルイセチオン酸Naを主とする原料(ISELUX) 10.0
ココイルメチルタウリンNa 10.0
ココイルグリシンK 15.0
ラウリルジメチルアミンオキシド 2.0
塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体 0.5
コカミドDEA 2.0
セラミド2 0.5
セラミド5 0.5
ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル) 0.5
ポリクオタニウム-67 0.1
N-アセチルグルコサミン 0.5
ヒアルロン酸Na 0.5
グリセリン 30.0
フェノキシエタノール 0.2
EDTA-2Na 0.05
クエン酸 適量
香料 適量
精製水 残余
Formulation Example 3 Facial cleanser Formulated amount (mass%)
Raw material mainly consisting of sodium lauroyl methyl isethionate (ISELUX) 10.0
Sodium methyl cocoyl taurate 10.0
Cocoyl glycine K 15.0
Lauryl dimethylamine oxide 2.0
Dimethyldiallylammonium chloride/acrylamide copolymer 0.5
Cocamide DEA 2.0
Ceramide 2 0.5
Ceramide 5 0.5
Lauroyl glutamate di(phytosteryl/octyldodecyl) 0.5
Polyquaternium-67 0.1
N-acetylglucosamine 0.5
Sodium hyaluronate 0.5
Glycerin 30.0
Phenoxyethanol 0.2
EDTA-2Na 0.05
Citric acid, appropriate amount Flavoring, appropriate amount Purified water, balance
Claims (2)
(A)アシルアルキルイセチオン酸塩、並びに前記アシルアルキルイセチオン酸塩の製造時の副生成物である脂肪酸及び/又は脂肪酸塩を含有する活性剤であって、前記アシルアルキルイセチオン酸塩の含有量は水を含まない前記活性剤の総量に対して80質量%以上100質量%未満である活性剤
(B)アミンオキシド型両性界面活性剤 A cleaning composition comprising the following components (A) and (B), wherein the blending amount of the component (A) is 0.1 to 50 mass % based on the entire cleaning composition, the blending amount of the component (B) is 0.1 to 10 mass % based on the entire cleaning composition, and the ratio of the component (A) to the component (B) ((A)/(B)) is 0.33 to 500:
(A) An active agent containing an acylalkylisethionate and a fatty acid and/or a fatty acid salt that is a by-product during the production of the acylalkylisethionate, the content of the acylalkylisethionate being 80% by mass or more and less than 100% by mass based on the total amount of the active agent excluding water. (B) An amine oxide type amphoteric surfactant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019237846A JP7502860B2 (en) | 2019-12-27 | 2019-12-27 | Cleaning composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019237846A JP7502860B2 (en) | 2019-12-27 | 2019-12-27 | Cleaning composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021104984A JP2021104984A (en) | 2021-07-26 |
JP7502860B2 true JP7502860B2 (en) | 2024-06-19 |
Family
ID=76918579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019237846A Active JP7502860B2 (en) | 2019-12-27 | 2019-12-27 | Cleaning composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7502860B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002309291A (en) | 2001-04-13 | 2002-10-23 | Lion Corp | Detergent composition |
JP2007146030A (en) | 2005-11-29 | 2007-06-14 | Lion Corp | Detergent composition |
JP2010538036A (en) | 2007-09-05 | 2010-12-09 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Stable liquid cleansing composition containing fatty acyl isethionate surfactant |
JP2013523626A (en) | 2010-03-26 | 2013-06-17 | インノスペック リミテッド | Composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653016B1 (en) * | 1989-10-13 | 1994-09-16 | Oreal | COMPOSITION FOR WASHING KERATINIC MATERIALS, ESPECIALLY HAIR AND / OR SKIN. |
-
2019
- 2019-12-27 JP JP2019237846A patent/JP7502860B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002309291A (en) | 2001-04-13 | 2002-10-23 | Lion Corp | Detergent composition |
JP2007146030A (en) | 2005-11-29 | 2007-06-14 | Lion Corp | Detergent composition |
JP2010538036A (en) | 2007-09-05 | 2010-12-09 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Stable liquid cleansing composition containing fatty acyl isethionate surfactant |
JP2013523626A (en) | 2010-03-26 | 2013-06-17 | インノスペック リミテッド | Composition |
Also Published As
Publication number | Publication date |
---|---|
JP2021104984A (en) | 2021-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4746327B2 (en) | Skin cleanser composition | |
JP2013163659A (en) | Skin detergent composition | |
JP2014125435A (en) | Skin cleanser composition | |
JP5836116B2 (en) | Concentrated liquid body cleaner composition | |
JP2008179583A (en) | Skin cleanser composition | |
JP6812099B2 (en) | Skin cleanser | |
JP2008094724A (en) | Skin cleanser composition | |
JP2010180181A (en) | Detergent composition | |
JP6062242B2 (en) | Concentrated liquid body cleaner composition | |
JP6029973B2 (en) | Skin cleanser composition | |
JP2010180182A (en) | Detergent composition | |
JP2012149198A (en) | Skin detergent composition | |
JP7204162B2 (en) | detergent composition | |
JP7217925B2 (en) | skin cleanser composition | |
JP2011037782A (en) | Wiping cleansing cosmetic | |
JP7502860B2 (en) | Cleaning composition | |
JP6990496B2 (en) | Detergent composition | |
JP6437289B2 (en) | Cleaning composition | |
JP7408379B2 (en) | cleaning composition | |
JP7467105B2 (en) | Cleaning composition | |
JP2016124828A (en) | Improving agent, preventing agent, and detergent composition for senile xerosis | |
JP2002003334A (en) | Cosmetic | |
JP2008179585A (en) | Skin detergent composition | |
JP2018127420A (en) | Skin detergent composition | |
JP2019014690A (en) | Detergent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221117 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231013 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20231019 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240417 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240604 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240607 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7502860 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |